Charles Schwab’s Lumexa Imaging Holdings LMRI Stock Holding History

Charles Schwab’s Portfolio LMRI Stock Details LMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.23M	Sell	198,058 -11,393	-5%	-$104K	﹤0.01%	2755
2026 Q1	$1.8M	Buy	+209,451	New	+$2.88M	﹤0.01%	2745

Other funds holding LMRI

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Think Investments San Francisco, California $847M AUM 88.1% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Charles Schwab's LMRI Position: Q2 2026 in Review

Charles Schwab reduced its Lumexa Imaging Holdings (LMRI) stake by 5.4% in Q2 2026, selling an estimated $104K and leaving 198,058 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2755.

Charles Schwab first reported a position in LMRI in Q1 2026 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold LMRI as of Q2 2026.

Charles Schwab held 198,058 shares of Lumexa Imaging Holdings worth $2.23M as of Q2 2026.
Charles Schwab sold 11,393 Lumexa Imaging Holdings shares in Q2 2026, an estimated $104K.
Lumexa Imaging Holdings made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2755 holding.
Charles Schwab first reported a position in Lumexa Imaging Holdings in Q1 2026 and has held it in 2 quarters since.
103 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.